Skip to content

Benzydamine Hydrochloride Gargle in Reducing Propofol for ERCP

Effectivity of Benzydamine Hydrochloride Gargle to Reduce Propofol Consumption in Endoscopic Retrograde Cholangiopancreatography Procedure

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04167592
Acronym
ERCP
Enrollment
72
Registered
2019-11-19
Start date
2018-08-01
Completion date
2018-10-01
Last updated
2019-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ERCP

Keywords

propofol, benzydamine hydrochloride, sore throat, Endoscopic Retrograde Cholangiopancreatography

Brief summary

It was a study aimed to determine the effectivity of benzydamine hydrochloride gargling in reducing propofol consumption in the Endoscopic Retrograde Cholangiopancreatography (ERCP) procedure.

Detailed description

The study was approved by Ethics Committee of Indonesia University. It was a single-blind randomized clinical trial at Cipto Mangunkusumo Hospital - Jakarta during August to September 2018. 72 subjects were recruited and randomly assigned into 2 groups. Patients in group B were given 0.15% mouthwash with benzydamine hydrochloride prior to procedure while patients in group C were given mouthwash with 15 ml of water. Cumulative propofol consumption per minute per kg body weight, and incidence of postoperative sore throat were measured for each group.

Interventions

Benzydamine Hydrochloride 0.15% Oral Rinse was used to gargle prior to Endoscopic Retrograde Cholangiopancreatography (ERCP) procedure.

DRUGWater

Water was used to gargle prior to Endoscopic Retrograde Cholangiopancreatography (ERCP) procedure.

Sponsors

Indonesia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* undergoing ERCP * ASA I-III * BMI 18-30 kg/m2

Exclusion criteria

* allergic to propofol * contraindicated to propofol * had throat wound or laceration * received analgesics or steroid in 24 hours priorly * unstable during sedation * procedure longer than 90 minutes

Design outcomes

Primary

MeasureTime frameDescription
Cumulative Propofol Consumption90 minutesAbout 1 mg/kg Propofol was initially administered to sedate the subjects. If the subject's RSS (Ramsay Sedation Scale) rose, 0.3 mg/kg was additionally given. The amount of propofol used, as in mg/kg, during the ERCP procedure was recorded.
Incidence of Sore Throat4 hoursSore throat incidence after ERCP procedure was recorded

Countries

Indonesia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026